Pure Global
NCT03124277

Nutritional Support for Rehabilitation In Parkinsonism

A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Patients With Parkinsonism Undergoing Rehabilitation Treatment: a Randomized Trial
Emanuele Cereda·ClinicalTrials.gov·dietary supplementCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Disability Physical
Drug/Device/Intervention
Fortifit®
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Emanuele Cereda
Funder
IRCCS Policlinico S. Matteo
Location
Milano, Italy
Timeline & enrollment
Phase
N/A
Start date
Apr 26, 2017
End date
Jan 17, 2018
Enrollment
150 participants
Primary outcome

Functional status - distance walked during the six minutes walking test

Summary

This randomized, trial will tested the hypothesis that nutritional supplementation with whey
 protein, essential amino acids - mainly leucine - vitamin D and calcium would increase the
 efficacy of physical rehabilitation in old adults suffering from Parkinson's disease o
 parkinsonism

ICD-10 classifications
Other physical therapyLimitation of activities due to disabilityDependence on wheelchairPostprocedural musculoskeletal disorders, not elsewhere classifiedFamily history of other disabilities and chronic diseases leading to disablement, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03124277
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03124277 through Pure Global AI's free database. This phase not specified trial is sponsored by Emanuele Cereda and is currently Completed. The study focuses on Disability Physical. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.